Grifols SA Company Profile (NASDAQ:GRFS)

Analyst Ratings

Consensus Ratings for Grifols SA (NASDAQ:GRFS) (?)
Ratings Breakdown: 1 Sell Rating(s), 2 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 2.20)
Consensus Price Target: $20.75 (20.29% upside)

Analysts' Ratings History for Grifols SA (NASDAQ:GRFS)
Show:
DateFirmActionRatingPrice TargetActions
6/6/2016Morgan StanleyReiterated RatingSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2016NomuraInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/9/2016Berenberg BankUpgradeHold -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/2/2015HSBCDowngradeBuy -> Hold$22.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/17/2015JPMorgan Chase & Co.Boost Price TargetNeutral$17.50 -> $19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2015Goldman Sachs Group Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/9/2014Bank of America Corp.DowngradeNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/27/2014 forward)

Earnings

Earnings History for Grifols SA (NASDAQ:GRFS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
3/12/2015$0.58$0.53ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/18/2014$0.51$0.44ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/15/2014$0.55$0.40ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Grifols SA (NASDAQ:GRFS)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.24$0.52$0.38
Q2 20162$0.26$0.55$0.41
Q3 20161$0.53$0.53$0.53
Q4 20161$0.57$0.57$0.57
Q1 20171$0.28$0.28$0.28
Q2 20171$0.30$0.30$0.30
Q3 20171$0.30$0.30$0.30
Q4 20171$0.33$0.33$0.33
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Grifols SA (NASDAQ:GRFS)
Annual Dividend:$0.27
Dividend Yield:1.57%
Payout Ratio:26.21% (Based on Current Year Consensus EPS Estimate)
23.89% (Based on Next Year Consensus EPS Estimate)

Dividend History for Grifols SA (NASDAQ:GRFS)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
5/31/2016$0.116/2/20166/6/20166/6/2016Tweet This Announcement  Share This Announcement on StockTwits
12/1/2015$0.3012/10/201512/14/201512/14/2015Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Grifols SA (NASDAQ:GRFS)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Grifols SA (NASDAQ:GRFS)
DateHeadline
07/26/16 04:28 PMTwo Movers inside Analysts Radar: Relypsa, Inc. (NASDAQ:RLYP) , Grifols, S.A. (NASDAQ:GRFS) - Street Updates
07/26/16 10:01 AMGrifols SA :GRFS-US: Earnings Analysis: Q1, 2016 By the Numbers : July 26, 2016 -
07/25/16 04:22 PMPrice Target of $17.272 Set For Grifols, SA (NASDAQ:GRFS) - RealistInvestor.com
07/25/16 12:29 PMETF’s with exposure to Grifols SA : July 25, 2016 -
07/22/16 07:11 AMGrifols, S.A. (NASDAQ:GRFS): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/20/16 05:41 PMIs Grifols, SA(NASDAQ: GRFS), a large market cap stock a smart buy? - The Daily Leicester
07/19/16 10:25 AMEarnings Focus and Crowd Sourced Sentiment Review for Grifols, S.A. (NASDAQ:GRFS) - TGP
07/19/16 10:25 AMGrifols, SA (NASDAQ:GRFS) – Top Stock from Healthcare Sector - The Daily Leicester
07/18/16 09:28 AMHC Stocks Impression: Grifols SA, Barcelona (NASDAQ:GRFS) Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) - share market updates (press release)
07/16/16 04:04 PMGrifols, SA (NASDAQ:GRFS) Given $17.272 Price Target - RealistInvestor.com
07/15/16 03:21 PMToday's Top Gainers in the Market Grifols, SA (NASDAQ:GRFS) from Healthcare - The Daily Leicester
07/14/16 04:26 PMGrifols, S.A. (NASDAQ:GRFS) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/14/16 04:26 PMNews review of 2 biotech stocks: Grifols, S.A. (NASDAQ:GRFS), Nektar Therapeutics (NASDAQ:NKTR) - The Voice Registrar
07/14/16 04:26 PMUpdate on Grifols, SA (NASDAQ:GRFS) for the day - Twin County News
07/14/16 07:44 AMAnalyst Target and Average Rating Watch: Grifols, S.A. (NASDAQ:GRFS) - Press Telegraph
07/14/16 07:44 AMNotable movements of Stocks: Perrigo Company (NYSE:PRGO) , Grifols, S.A. (NASDAQ:GRFS) - Street Updates
07/13/16 04:40 PMBroker Outlook For Grifols, S.A. (NASDAQ:GRFS) - Fiscal Standard
07/13/16 07:09 AMGrifols, S.A. (NASDAQ:GRFS) Wall Street Analyst Recommendation Outlook - Telanagana Press
07/13/16 07:09 AMLeading stocks in today's market: Grifols, SA (NASDAQ:GRFS) - Twin County News
07/12/16 11:20 AMGrifols SA : GRFS-US: Dividend Analysis : June 06th, 2016 (record date) : By the numbers : July 12, 2016 -
07/09/16 03:57 PMGrifols, SA (NASDAQ:GRFS) Awarded Price Target of $17.272 - RealistInvestor.com
07/08/16 04:19 PMWill Grifols, S.A. (NASDAQ:GRFS) Surprise This Quarter? - Investor Newswire
07/08/16 07:08 AMGrifols, SA (NASDAQ:GRFS) from Biotechnology – Todays Top Gains - Twin County News
07/07/16 07:09 AMCompany Stock Focus for Grifols, S.A. (NASDAQ:GRFS): Which Way Will Shares Head? - Press Telegraph
07/07/16 07:09 AMHow has Grifols, SA:(NASDAQ:GRFS) performed recently? - The Daily Leicester
07/06/16 04:30 PMA look at a High Market Cap Stock: Grifols, SA, GRFS - The Daily Leicester
07/06/16 08:58 AMLos Angeles County to Host Mass Transit Rail, Pharma and Solar Projects
07/05/16 09:01 AMPedigri®: the tool that increases the information transparency to the plasma-derived manufactured in Clayton - [at noodls] - GammaSTAN, Gamunex / Gamunex-C, HyperHEP B, HyperRAB, HyperRHO, HyperTET, Koāte DVI, Plasbumin, Prolastin / Prolastin C and Thrombate III are the newly added products. Grifols has been offering this unique ...
07/04/16 03:55 PMRock Point Advisors LLC Increased Grifols B Adr (NASDAQ:GRFS) by $3.00 Million as Shares Rose - Press Telegraph
07/04/16 03:55 PMWhat's in Grifols SA, Barcelona After Today's Gap Up? - Press Telegraph
07/02/16 04:10 PMGrifols, SA (NASDAQ:GRFS) Low Price Is Set At $15 - RealistInvestor.com
07/02/16 07:12 AMMega Cap End of Session Update: Grifols, S.A. (NASDAQ:GRFS) - Telanagana Press
06/30/16 11:08 AMETF’s with exposure to Grifols SA : June 30, 2016 -
06/30/16 02:21 AMAward Winners of the 9th Annual Martín Villar Haemostasis Awards - [at noodls] - Created in 2007, the awards recognize the progress made in the field of Hemostasis. The awards are endowed with 20,000 euros for each of the two prizes: Basic Research and Clinical Research. The Basic ...
06/29/16 01:42 PMGrifols SA : GRFS-US: Dividend Analysis : June 06th, 2016 (record date) : By the numbers : June 29, 2016 -
06/29/16 01:31 AMAward Winner of the 2016 SPIN Awards Program - [at noodls] - Created in 2008, the SPIN Awards Program supports the development and testing of innovative ideas and hypotheses in the field of immunoglobulin research in neurology. The research project was awarded to ...
06/28/16 09:10 AMBluecrest Capital Management LTD Increased Grifols S A (NASDAQ:GRFS) by $7.56 Million as Shares Rose - Engelwood Daily
06/25/16 08:09 AMWhat's Propelling Grifols SA, Barcelona to Decline So Much? The Stock Gaps Down Today - Engelwood Daily
06/23/16 07:14 AMHC Stocks in Front Line: Incyte Corporation (NASDAQ:INCY), Grifols SA, Barcelona (NASDAQ:GRFS) - share market updates (press release)
06/22/16 10:33 PMGrifols SA : GRFS-US: Dividend Analysis : June 06th, 2016 : By the numbers : June 23, 2016 -
06/22/16 11:54 AMGrifols SA :GRFS-US: Earnings Analysis: Q1, 2016 By the Numbers : June 22, 2016 -
06/21/16 08:55 AMGrifols : FDA Approves Use of the Procleix Zika Virus Assay from Hologic and Grifols to Screen the U.S. Blood Supply Under an IND Study Protocol
06/20/16 08:53 AMZika Blood Screening Test From Hologic, Grifols Gets FDA Nod -
06/20/16 07:00 AMFDA Approves Use of the Procleix Zika Virus Assay from Hologic and Grifols to Screen the U.S. Blood Supply Under an IND Study Protocol - [PR Newswire] - MARLBOROUGH, Mass. and EMERYVILLE, Calif., June 20, 2016 /PRNewswire/ -- Hologic, Inc. (HOLX) and Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) – market-leading partners committed to blood safety - announced today that the U.S. Food and Drug Administration (FDA) has approved use of the Procleix Zika virus blood screening assay on the Procleix Panther system under the agency's Investigational New Drug (IND) study protocol. Prominent U.S. blood centers will use the Procleix Zika virus assay to screen donated blood collected in potential endemic areas of the southern U.S., and may expand testing to other areas of the U.S. if the virus continues to spread. "The American Red Cross is pleased to participate in the Procleix Zika Virus assay investigational study, which will allow us to begin blood donor testing for Zika virus early this summer in areas most likely to have local mosquito transmission of the virus," said Susan Stramer, Ph.D., Vice President of Scientific Affairs at the American Red Cross.
06/16/16 08:05 AMAnalyzing IBB’s Moving Averages -
06/16/16 12:49 AMGrifols confirms that it has voluntarily signed the EFPIA Code of Conduct - [at noodls] - Barcelona, June 15, 2016. Grifols released its Corporate Social Responsibility policy on May 26, 2016, via the Spanish stock exchange regulator, the CNMV, and announced its decision to voluntarily adopt ...
06/05/16 04:15 PMHow Many Grifols SA, Barcelona (NASDAQ:GRFS)'s Analysts Are Bullish? - HNN
06/03/16 04:29 AMNews Buzz: Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), Grifols SA, Barcelona (NASDAQ:GRFS) - NYSE Journal (press release) - News Buzz: Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), Grifols SA, Barcelona (NASDAQ:GRFS)NYSE Journal (press release)On Thursday, Shares of Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), added 15.42% and closed at $0.583 in the last trading session. The last trading range of the stock ranges between $0.51 and $0.64. Sunesis Pharmaceuticals, Inc. (SNSS) recently ...and more »
06/01/16 04:36 PMEli Lilly and Co (NYSE:LLY) & Grifols SA, Barcelona (NASDAQ:GRFS) Healthcare Hot Stock's Alert - Wall Street 24 - Eli Lilly and Co (NYSE:LLY) & Grifols SA, Barcelona (NASDAQ:GRFS) Healthcare Hot Stock's AlertWall Street 24On Tuesday, Shares of Eli Lilly and Co (NYSE:LLY) gained 0.05% to $75.03. The share price is trading in a range of $74.71 – $75.63. The stock exchanged hands with 4.44 Million shares contrast to its average daily volume of 4.02 Million shares. The U.S. ...and more »
06/01/16 08:07 AMGrifols Maintains Its Dividend Payout at 40% -

Social

About Grifols SA

Grifols SA logo

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: GRFS
  • CUSIP:
Key Metrics:
  • Previous Close: $17.25
  • 50 Day Moving Average: $16.47
  • 200 Day Moving Average: $15.60
  • P/E Ratio: 40.83
  • P/E Growth: 1.11
  • Market Cap: $23.58B
  • Beta: 1
  • Current Year EPS Consensus Estimate: $1.03 EPS
  • Next Year EPS Consensus Estimate: $1.13 EPS
Additional Links:
Grifols SA (NASDAQ:GRFS) Chart for Wednesday, July, 27, 2016